Safe Science

Safe Science Solutions is a Canadian life sciences company dedicated to addressing the global narcotic overdose and opioid addiction epidemic. The company employs a comprehensive "prevent, protect, and prevail" strategy, offering a portfolio that includes FDA-cleared wearable neurostimulation devices for managing opioid withdrawal, injectable naloxone hydrochloride for overdose reversal, and proprietary fentanyl detection strips. Additionally, Safe Science is advancing a pharmaceutical pipeline of synthetic agonists specifically designed for the treatment of addiction. Led by a team of veteran pharmaceutical executives and former government health officials, the company is currently transitioning to public markets via a reverse takeover announced in late 2024.